MergerLinks Header Logo

Submit Deal

Submit Deal

Announced

Completed

Haleon completed the acquisition of the remaining 12% stake in Tianjin TSKF Pharmaceutical for $222m.

Synopsis

Haleon, a British multinational consumer healthcare company, completed the acquisition of the remaining 12% stake in Tianjin TSKF Pharmaceutical, a pharmaceutical company, for $222m.

Principals

Tianjin Tskf Pharmaceutical

target

Tianjin Tskf Pharmaceutical

HALEON

bidder

HALEON

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Bidder Team (12)

jr

jo russell

Head of Investor Relations at HALEON

Manager

bidder

1

Deal

£ 169 M

Total Value

rp

rakesh patel

Investor Relations at HALEON

Manager

bidder

4

Deals

£ 1.48 B

Total Value

ew

emma white

Investor Relations at HALEON

Manager

bidder

4

Deals

£ 1.48 B

Total Value

zb

zoë bird

Global Head of Communications at HALEON

Manager

bidder

2

Deals

£ 644 M

Total Value

vd

victoria durman

Investor Relations at HALEON

Manager

bidder

1

Deal

£ 169 M

Total Value

bm

brian mcnamara

CEO at HALEON

Manager

bidder

6

Deals

£ 11.28 B

Total Value

dc

david campbell

A&O Shearman

Lawyer

bidder

3

Deals

£ 3.14 B

Total Value

aj

akshita jha

Associate at A&O Shearman

Lawyer

bidder

2

Deals

£ 169 M

Total Value

zs

zara sproul

Senior Associate at A&O Shearman

Lawyer

bidder

11

Deals

£ 11.16 B

Total Value

ma

matthew appleton

Partner at A&O Shearman

Lawyer

bidder

25

Deals

£ 30.09 B

Total Value

mb

matthew bisley

Partner at A&O Shearman

Lawyer

bidder

1

Deal

£ 169 M

Total Value

vc

vivian cao

PARTNER at A&O Shearman

Lawyer

bidder

1

Deal

£ 169 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite